Important ethical issues for nanomedicine
Sora Yasri1, Viroj Wiwanitkit2
1 KMT Primary Care Center, Bangkok, Thailand
2 Department of Tropical Medicine, Hainan Medical University, Hainan Sheng, China; Department of Community Medicine, Dr. DY Patil University, Pune, Maharashtra, India; Department of Medical Science, Faculty of Medicine, University of Nis, Nis, Serbia; Department of Biological Science, Joseph Ayobabalola University, Ilara-Mokin, Nigeria
|Date of Web Publication||26-Dec-2017|
Dr. Sora Yasri
KMT Primary Care Center, Bangkok
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Yasri S, Wiwanitkit V. Important ethical issues for nanomedicine. J Res Med Sci 2017;22:138
Nanotechnology is presently a widely used new technology. At present, it can be applied in several fields including medicine. Without regulation, unexpected and unwanted adverse events due to applied nanotechnology in nanomedicine can be expected. At first, since the nanotechnology can be applied in many medical purposes including drug and diagnostic test development, it can sometimes be a way to make profit of some unethical persons. In nanomedicine, the ethical issue is a very important issue for control of the use of the new nanotechnology by human beings. Good practice based on “unhidden agenda” of the new nanosubstance is required. The efficacy, effectiveness, and safety are important issues to be considered before implementation of any new nanotechnology in medicine. Ethical practice is required for any steps of application of nanomedicine technology. For diagnosis, the basic principle of privacy of the patient is still important. In general, data ownership and privacy and data confidentiality are the main topics to be considered when nanotechnology is applied for health purposes.
For treatment, the protection of patient's right is very important, and there must be the act against the violation of patient's right. Without complete information on effectiveness and safety of the newly used nanosubstances in medicine, it might be a violation to the informed consent principle. At the same time, the protection of the practitioner who has to come into contact with the newly used nanomaterial is also needed. As noted by Allon et al., “Some interpreters agree that advances in nanotechnology may pose varied ethical challenges, whilst others argue that these challenges are not new and that nanotechnology basically echoes recurrent bioethical dilemmas.” The authors hereby would like to draw the attention of the medical scientist to recognize and have a concern on the ethical issue regarding the emerging new nanotechnology in medicine [Table 1]. Internationally, collaboration and implementation of local and international law for control of the use of nanotechnology in nanomedicine is an important requirement against the possible emerging misconduct and unethical practice in medicine.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Satalkar P, Elger BS, Shaw DM. Stakeholder views on participant selection for first-in-human trials in cancer nanomedicine. Curr Oncol 2016;23:e530-7.
King NM. Nanomedicine first-in-human research: Challenges for informed consent. J Law Med Ethics 2012;40:823-30.
Allon I, Ben-Yehudah A, Dekel R, Solbakk JH, Weltring KM, Siegal G, et al.
Ethical issues in nanomedicine: Tempest in a teapot? Med Health Care Philos 2017;20:3-11.
Manchikanti P, Uppala S, Bonta RK. Patents in nanobiotechnology: A Cross jurisdictional approach. Recent Pat Biotechnol 2017;11:52-70.